Ex02 CAR-T
/ Zeno Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 15, 2024
EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=9 | Recruiting | Sponsor: Zhimin Zhai
CAR T-Cell Therapy • New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
January 09, 2024
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
(clinicaltrials.gov)
- P1 | N=6 | Not yet recruiting | Sponsor: Zhang Xiaofeng,MD
New P1 trial • Biliary Cancer • Cholangiocarcinoma • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1